{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T14:31:30Z","timestamp":1697293890099},"reference-count":25,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,6,25]],"date-time":"2009-06-25T00:00:00Z","timestamp":1245888000000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine"],"published-print":{"date-parts":[[2009,6]]},"abstract":"<jats:title><jats:sc>summary<\/jats:sc>.<\/jats:title><jats:p>This study investigated whether filtration of leucodepleted red cells in SAG\u2010M through the P\u2010CAPT\u2122 filter in order to prevent the potential risk of vCJD infection associated with prion transmission through transfusion has any deleterious effect on red\u2010cell quality. Bottom\u2010and\u2010top SAG\u2010M leucodepleted red\u2010cell concentrates (24 units) were prion\u2010reduction filtered on the day following collection, with half of the units undergoing irradiation on day 14. A control group (12 units) was not prion filtered. Units were sampled at 7\u2010day intervals up to day 35 and tested using standard measures of red\u2010cell quality as well as prothrombin content (to examine prion filter efficacy). Haemoglobin loss per unit was \u223c9 g and in some cases levels were below standard specification (40 g). Haemolysis increased significantly after filtration [0.01 (0.00\u20100.05) vs. 0.23 (0.07\u20100.52, p&lt;0.001)]. Prothrombin levels were reduced 41.6\u2010fold compared to leucodepleted red\u2010cell units. Product specifications were within or close to routine acceptable levels. Owing to the reduction in haemoglobin levels below those specified, it may be preferable to reduce haemoglobin specification levels and transfuse more prion\u2010filtered units rather than transfuse potentially unsafe blood product. The risk of transfusing more units with less haemoglobin should be offset against the risk of transfusing unfiltered blood.<\/jats:p>","DOI":"10.1111\/j.1365-3148.2009.00918.x","type":"journal-article","created":{"date-parts":[[2009,6,25]],"date-time":"2009-06-25T07:48:00Z","timestamp":1245916080000},"page":"109-116","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["<i>In vitro<\/i> assessment of red\u2010cell concentrates in SAG\u2010M filtered through the MacoPharma\u2122 P\u2010CAPT prion\u2010reduction filter"],"prefix":"10.1111","volume":"19","author":[{"given":"C. V.","family":"Murphy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Eakins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Fagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Croxon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. G.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,6,25]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.03225.x"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3148.2000.00230.x"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)91958-4"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1999.39111169.x"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1998.38998408999.x"},{"key":"e_1_2_6_7_1","volume-title":"Guide to the Preparation, Use and Quality Assurance of Blood Components","author":"Council of Europe Publishing","year":"2004"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90068-R"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69897-8"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2006.00865.x"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16812-8"},{"key":"e_1_2_6_12_1","unstructured":"Guidelines for the Blood Transfusion Services in the United Kingdom 7th Edn. (2005) The Stationery Office Ltd.http:\/\/www.transfusionguidelines.org.uk\/(last accessed 10\/7\/2008)."},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)12075-5"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02719-7"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-152520"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1538-7836.2003.00268.x"},{"key":"e_1_2_6_17_1","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/37789","article-title":"A crucial role for B cells in neuroinvasive scrapie","author":"Klein M.A.","year":"1997","journal-title":"Nature"},{"key":"e_1_2_6_18_1","first-page":"2102","volume-title":"Methods of Enzymatic Analysis","author":"Lamprecht W.","year":"1974"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15486-X"},{"key":"e_1_2_6_20_1","unstructured":"National Creutzfeldt\u2013Jakob Disease Surveillance Unit (NCJDSU) UKhttp:\/\/www.cjd.ed.ac.uk\/vcjdworld.htm4 July (2008) (Accessed 10\/7\/2008)."},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16811-6"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2005.00703.x"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2006.00765.x"},{"key":"e_1_2_6_24_1","unstructured":"United Kingdom Health Protection Agency (HPA)Variant CJD and blood donors and recipients(updated 9 April 2008).http:\/\/www.hpa.org.uk\/infections\/topics_az\/cjd\/menu.htm."},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1101(1999)14:3<135::AID-JCA6>3.0.CO;2-S"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7252.17"}],"container-title":["Transfusion Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-3148.2009.00918.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-3148.2009.00918.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T00:31:08Z","timestamp":1696897868000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-3148.2009.00918.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["10.1111\/j.1365-3148.2009.00918.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-3148.2009.00918.x","archive":["Portico"],"relation":{},"ISSN":["0958-7578","1365-3148"],"issn-type":[{"value":"0958-7578","type":"print"},{"value":"1365-3148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6]]},"assertion":[{"value":"2009-06-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}